e-learning
resources
Stockholm 2002
Monday 16.09.2002
Lung Physiology: clinical
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of the echocardiographic and pulmonary function test findings in treated and untreated hypertensive patients
A. Guven, N. Koksal, E. Caglayan (Kahramanmaras, Turkey)
Source:
Annual Congress 2002 - Lung Physiology: clinical
Session:
Lung Physiology: clinical
Session type:
Thematic Poster Session
Number:
1883
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Guven, N. Koksal, E. Caglayan (Kahramanmaras, Turkey). Comparison of the echocardiographic and pulmonary function test findings in treated and untreated hypertensive patients. Eur Respir J 2002; 20: Suppl. 38, 1883
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Assessment of pulmonary perfusion by MR in patients suffering from pulmonary arterial hypertension (PAH) in comparison to healthy volunteers
Source: Eur Respir J 2006; 28: Suppl. 50, 424s
Year: 2006
Prognostic significance of right ventricular dysfunction detected by CT/Echocardiography and biomarkers in normotensive patients with pulmonary embolism
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
Comparison of pulmonary function in diabetic patients with and without retinopathy and comparing to control group
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009
Evaluation of the relationship between laboratory parameters and pulmonary function tests in COVID-19 patients
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021
Echocardiographic measures of right ventricular function poorly correlate with changes in contractility and coupling in treatment naïve patients with pulmonary artery hypertension before and after therapy.
Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension
Year: 2017
Haemodynamic correlation and prognostic value of ventricular mass index (VMI) in non-surgically treated chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
Correlation of spirometric value to 2D ECHO parameters for diagnosis of pulmonary hypertension in COPD
Source: International Congress 2018 – Functional assessment of COPD
Year: 2018
Sitaxsentan for pulmonary arterial hypertension (PAH) patients with clinical deterioration or significantly abnormal liver function test on bosentan
Source: Eur Respir J 2005; 26: Suppl. 49, 563s
Year: 2005
Baseline profile of patients initiating sitaxentan for pulmonary arterial hypertension (PAH): preliminary results from thelin outcomes for patients surveillance (TOPS)
Source: Annual Congress 2008 - Pulmonary hypertension II
Year: 2008
Ergospirometry findings in patients with scleroderma in relation to concurrent pulmonary hypertension
Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases
Year: 2010
Comparison of the epidemiological radio-clinical and evolutive profile of pulmonary tuberculosis in diabetic patients and non diabetic ones
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006
Echocardiographic findings in male patients with OSA: before and after positive airway pressure
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009
Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses
Source: Eur Respir J 2013; 42: 1575-1585
Year: 2013
Prevalence of pulmonary hypertension among outpatients with sarcoidosis: An echocardiographic and pulmonary catheterization study
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012
The rehabilitative treatment by Free-aspire
Ò
can reduce pulmonary hypertension in patients with post- cardiac surgery heart failure. Hemodynamic evaluation of echocardiographic parameters
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010
Early diagnostic evaluation of pulmonary hypertension in severe COPD patients (preliminary results)
Source: Eur Respir J 2006; 28: Suppl. 50, 657s
Year: 2006
Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Long-term lung function follow-up in patients diagnosed and treated for pulmonary tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Relationship between exercise tolerance and spirometric data in a group of patients affected by idiopathic dilated cardiomyopathy
Source: Eur Respir J 2001; 18: Suppl. 33, 84s
Year: 2001
Effects of oral dual ERA therapy on pulmonary function testing and 6MWT in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept